Evidence map›Paper›PMID 17610951›Full record

ArticleCell calcium2008

Inositol 1,4,5-trisphosphate receptor movement is restricted by addition of elevated levels of O-linked sugar.

Craig J Gibson, Barbara E Ehrlich

Abstract read
In one paragraph

Article in Cell calcium, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. IPeLife · 2020
    Article
  2. Spatial-temporal patterning of CaSeminars in cell & developmental biology · 2019
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Craig J GibsonDepartment of Pharmacology, Yale University, New Haven, CT 06520, United States.
Barbara E Ehrlich
Yale University · US

Funding

YALE CENTER FOR THE STUDY OF POLYCYSTIC KIDNEY DISEASEP50DK057328 · NIDDK · YALE UNIVERSITY · PI SOMLO, STEFAN · 1999 to 2009
$11.1M
Howard Hughes Medical InstituteNIDDK NIH HHS P50 DK057328
6 · The paper itself

Abstract

The inositol 1,4,5-trisphosphate receptor (InsP3R) is a versatile, ubiquitous intracellular calcium channel. Traditionally, visualizing the InsP3R in live cells involves attaching a fluorescent marker to either terminal of the protein, but the termini themselves contain binding sites for accessory molecules and proteins. Using random transposition, constructs have been developed that express the type I InsP3R with green fluorescent protein (GFP) inserted at various points within its sequence. We have used two of these constructs, one in the ligand-binding domain, and another in the regulatory domain, to investigate InsP3R dynamics within the endoplasmic reticulum. We present evidence that endogenous calcium signaling is maintained when these constructs are expressed. In addition, by measuring the fluorescent recovery after photobleaching of a subcellular region, we demonstrate that treatment with 8mM N-acetylglucosamine (GlcNAc), known to lead to increased O-linked GlcNAcylation of proteins, leads to a reduction in the ability of the InsP3R to travel laterally within the endoplasmic reticulum. Each construct serves as the control for the other one, suggesting that this decrease in mobility is not specific to the insertion site of GFP within the InsP3R. These constructs represent a new tool that will allow us to follow receptor turnover and translocation events.

Indexed as

MovementAcetylglucosamineAnimalsCalcium SignalingCell LineDogsEndoplasmic ReticulumFluorescence Recovery After PhotobleachingGreen Fluorescent ProteinsHumansInositol 1,4,5-Trisphosphate ReceptorsProtein TransportRecombinant Fusion ProteinsAcetylglucosamineGreen Fluorescent ProteinsInositol 1,4,5-Trisphosphate ReceptorsRecombinant Fusion Proteins

Identifiers

PMID17610951
PMCPMC3388802
OpenAlexW2020495876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.